News

We would like to make parents of children with epilepsy aware of a recent packaging and product change associated with Levetiracetam (Keppra) 150ml oral solution for children aged 6mths to 4 years. 

As a result of a change in the type of syringe which is used and packaged with the medication, the Health Product Regulatory Authority have issued a safety notice via a Dear Healthcare Professional communication. 

We are delighted to be benefiting from the third book of budding Kildare author Roisin Coyne!

Roisin published her first book while still in secondary school, and through each of her publications, has chosen to support a charity close to her heart – with €500 from the sales of each of her books going towards her chosen charity. 

A study in University College Cork wants to explore how people disclose their diagnosis of a long-term health condition. Can you help with this research?

These are a few tips for people living with epilepsy and their families to remember during this warm and sunny weather.

The European Medicines Agency's Pharmacovigilance Risk Assessment Committee recently decided to keep the precautionary safety measures associated with Sodium Valproate treatment in men. Read more about the measures here.

We are looking forward to working with colleagues in FutureNeuro on the EPI-SLEEP study, which will evaluate the use of sleep technology in adults with epilepsy.

If you or a loved one are taking the Anti Seizure Medication, Ontozry, please familiarise yourself with important new safety measures associated with the medication following the emergence of new data.

Good luck to the Leaving Cert class of 2026!

Epilepsy Ireland addresses Sodium Valproate inquiry

It's the last week for nominations for the AIB Community Fund and we'd really appreciate your support to be in with a chance of potentially receiving funding of up to €20,000!